APA (7th ed.) Citation

Xiao, J., Kim, J., Park, B., Baylink, D. J., Kwon, C., Tran, V., . . . Mirshahidi, H. (2025). Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRASG12D-mutated pancreatic cancer. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00669-w

Chicago Style (17th ed.) Citation

Xiao, Jeffrey, et al. "Targeting DNA Helicase CMG Complex and NFκB2-driven Drug-resistant Transcriptional Axis to Effectively Treat KRASG12D-mutated Pancreatic Cancer." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00669-w.

MLA (9th ed.) Citation

Xiao, Jeffrey, et al. "Targeting DNA Helicase CMG Complex and NFκB2-driven Drug-resistant Transcriptional Axis to Effectively Treat KRASG12D-mutated Pancreatic Cancer." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00669-w.